| 18 ans et plus
- | Pays :
- France
- | Organes :
- Prostate
- | Spécialités :
- Radiothérapie
- Thérapies Ciblées
Extrait
A randomized, double-blind, phase 3 trial comparing ipilimumab vs. placebo following radiotherapy in subjects with castration resistant prostate cancer that have received prior treatment with docetaxel.
Extrait Scientifique
en cours d'intégration;